glp 1 ra que es GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes The Role of GLP-1RA Medications

No clinic, no waiting room, no referral needed

For the beneficiary to qualify, a provider must submit a prior authorization request to the program that attests the beneficiary is prescribed the requested drug to reduce excess body weight and maintain weight reduction in combination with current and ongoing lifestyle modification including structured nutrition and physical activity consistent with the applicable FDA approved label, and the beneficiary is at least 18 years of age with a BMI greater than or equal to 35. For beneficiaries with underlying medical conditions, the BMI threshold is lowered to 30 or 25 based on the diagnosis

In instances where ED develops following GLP-1 RA therapy, discontinuation is indicated, accompanied by a thorough urological evaluation

GLP-1 receptor agonists reduce body weight by decreasing food intake, improving insulin sensitivity as well as delaying gastric emptying

The drug did not make her well, but rather quickly, she was able to get out of bed and walk around her house and use a walker instead of a wheelchair